Trial Profile
Chronic hepatitis C in illicit drug users and the role of antiviral therapy: the ARNICA project (Antiviral tReatment for chroNic hepatItis C in Active substance users).
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 May 2012
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C; HIV infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms ARNICA
- 03 Aug 2011 New trial record